Received Oct 31, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | UNK | — | IM |
shingles; Covid; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (shingles) and COVID-19 (Covid) in an adult female patient who received mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) for COVID-19 prophylaxis. Co-suspect product included Pre-filled Syringe injection for COVID-19 prophylaxis. The patient's past medical history included Breast cancer in 2023, Splenectomy (No spleen) and Pancreatectomy (No spleen and 1/2 pancreas). In September 2024, the patient received dose of mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) (Intramuscular use) 1 dosage form. On an unknown date, the patient started Pre-filled Syringe (unknown route) at an unspecified dose. On an unknown date, the patient experienced HERPES ZOSTER (shingles) and COVID-19 (Covid). At the time of the report, HERPES ZOSTER (shingles) had resolved and COVID-19 (Covid) outcome was unknown. No concomitant medication was reported. It was unknown if the patient experienced any additional symptoms/events. No treatment information was provided.
Medical History/Concurrent Conditions: Breast cancer; Pancreatectomy (No spleen and 1/2 pancreas); Splenectomy (No spleen)